Informaciones
Psiquiátricas
2016 - n.º 226
103
Referencias
1. Koskinen J, Löhönen J, Koponen H,
Isohanni M, Miettunen J. Rate of can-
nabis use disorders in clinical sam-
ples of patients with schizophrenia: a
meta-analysis. Schizophr Bull 2010;
36(6):1115-30.
2. Moore T, Zammit S, Lingford-Hughes A,
Barnes T, Jones P, Burke M et al. Canna-
bis use and risk of psychotic or affecti-
ve mental health outcomes: a systema-
tic review. Lancet 2007; 370: 319-328.
3. Andreasson S, Allebeck P, Engstrom A
et al. Cannabis and schizophrenia.Alon-
gitudinal study of Swedish conscripts.
Lancet 1987; 1483-1486.
4. Di Forti M, Sallis H, Allegri F, Trotta A,
Ferraro L, Stilo SA, Marconi A, La Cascia
C, Reis Marques T, Pariante C, Dazzan P,
Mondelli V, Paparelli A, Kolliakou A, Pra-
ta D, Gaughran F, David AS, Morgan C,
Stahl D, Khondoker M, MacCabe JH, Mu-
rray RM. Daily use, especially of high-
potency cannabis, drives the earlier
onset of psychosis in cannabis users.
Schizophr Bull. 2014; 40(6):1509-17.
5. Arseneault L, Cannon M, Witton J, Mu-
rray RM. Causal association between
cannabis and psychosis: examination
of the evidence. British Journal of
Psychiatry 2004; 184 (2):110-117.
6. Mané A, Fernández-Expósito M, Bergé D,
Gómez-Pérez L, Sabaté A, Toll A, Díaz
L, Díez-Aja C, Pérez V. Relationship bet-
ween cannabis and psychosis: Reasons
for use and associated clinical variables.
Psychiatry Res 2015; 30:229(1-2):70-4.
7. Vázquez-Barquero J L et al. Cantabria
First-Episode Schizophrenia Study:
Three-Year Follow-Up. British Journal
of Psychiatry 1999; 174:141-9.
8. Shepherd RT. Mechanisms of sudden
death associated with volatile subs-
tance abuse. Human Roxicology 1989;
8:287.
9. Álvarez-Jiménez M, Parker AG, Hetrick
SE, McGorry PD, Gleeson JF. Preven-
ting the second episode: a systematic
review and meta-analysis of psychoso-
cial and pharmacological trials in first-
episode psychosis. Schizophr Bull 2011;
37(3):619-30.
10. Stone JM, Fisher HL, Major B, Chisholm
B, Woolley J, Lawrence J, Rahaman N,
Joyce J, Hinton M, Johnson S, Young
AH. Cannabis use and first-episode
psychosis: relationship with manic and
psychotic symptoms, and with age
at presentation. Psychol Med. 2014;
44(3):499-506.
11. Van der Meer FJ, Velthorst E. Course of
cannabis use and clinical outcome in
patients with non-affective psychosis:
a 3-year follow-up study. Psychol Me.
2015; 45(9):1977-88.
12. Kemp RA1, Lambert TJ. Insight in
schizophrenia and its relationship to
psychopathology. Schizophr Res 1995;
18(1):21-8.
13. Jónsdóttir H1, Opjordsmoen S, Birke-
naes AB, Simonsen C, Engh JA, Ringen
PA, Vaskinn A, Friis S, Sundet K, An-
dreassen OA. Predictors of medication
adherence in patients with schizophre-
RELACIÓN ENTRE CANNABIS Y PSICOSIS: VARIABLES CLÍNICAS
